BLCM
Bellicum Pharmaceuticals, Inc. (BLCM)
$1.04
Market is closedMarket is closed – opens on 8 PM, 01 Dec 2022
– opens on 8 PM, 01 Dec 2022
Key Stats
$1.04
Day's Range
$1.07
$0.9316
52-Week Range
$2.2
| Returns | |
| 1 month return | 5.02% |
| 3 month return | 8.16% |
| 1 year return | 39.88% |
| 5 year return | 98.97% |
Company Information
Bellicum is a clinical stage biopharmaceutical company striving to deliver cures through controllable cell therapies. The company's next-generation product candidates are differentiated by powerful cell signaling technologies designed to produce more effective CAR-T cell therapies. Bellicum's GoCAR-T® product candidates, BPX-601 and BPX-603, are designed to be more efficacious CAR-T cell products capable of overriding key immune inhibitory mechanisms.
| Organization | Bellicum Pharmaceuticals, Inc. |
| Employees | 7 |
| CEO | Mr. Richard A. Fair |
| Industry | Health Technology |
Analyst Recommendation
based on 3 analysts ratings
Hold
33%
Buy
66%
Hold
0%
Sell
Based on 3 Wall street analysts offering stock ratings for Bellicum Pharmaceuticals, Inc.(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 380.77%Current
$1.04
Target
$5.0
Recommendation Trend
Based on 3 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 1 | 6 | 6 |
| Hold | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | HOLD | BUY | BUY |
Company Financials
Highlights
| Market Capitalization | 9.1M |
| Book Value | $0.87 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0% |
| Earnings Per Share (EPS) | 0.12 |
| PE Ratio | 8.77 |
| PEG Ratio | 0.0 |
| Wall Street Target Price | 5.0 |
Valuation
| Trailing PE | 8.77 |
| Forward PE | 0.0 |
| Price/Book (mrq) | 1.23 |
| Enterprise Value | -36939527 |
| Enterprise Value/Revenue | 1.33 |
| Enterprise Value/Ebitda | 2.28 |
Technicals
| Beta | 1.25 |
| 50 Day MA | 1.09 |
| 200 Day MA | 1.38 |
Institutional Holdings
Ikarian Capital, LLC
5.2%
Vanguard Group Inc
4.23%
Long Focus Capital Management, LLC
3.8%
Baker Bros Advisors LP
2.89%
Geode Capital Management, LLC
0.85%
Boxer Capital LLC
0.66%
Discover more
Frequently Asked Questions
What is Bellicum Pharmaceuticals, Inc. share price today?
Can Indians buy Bellicum Pharmaceuticals, Inc. shares?
How can I buy Bellicum Pharmaceuticals, Inc. shares from India?
Can Fractional shares of Bellicum Pharmaceuticals, Inc. be purchased?
What are the documents required to start investing in Bellicum Pharmaceuticals, Inc. stocks?
What are today’s High and Low prices of Bellicum Pharmaceuticals, Inc.?
What are today’s traded volumes of Bellicum Pharmaceuticals, Inc.?
What is today’s market capitalisation of Bellicum Pharmaceuticals, Inc.?
What is the 52 Week High and Low Range of Bellicum Pharmaceuticals, Inc.?
How much percentage Bellicum Pharmaceuticals, Inc. is down from its 52 Week High?
How much percentage Bellicum Pharmaceuticals, Inc. is up from its 52 Week low?
What are the historical returns of Bellicum Pharmaceuticals, Inc.?
Who is the Chief Executive Officer (CEO) of Bellicum Pharmaceuticals, Inc.?
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*